JAWM
MRNA icon

J. Arnold Wealth Management’s Moderna MRNA Stock Holding History

J. Arnold Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,238
Closed -$1.63M – 64
2021
Q3 		$1.63M Buy
4,238
+258
+6% +$95.2K 0.79% 14
2021
Q2 		$935K Sell
3,980
-740
-16% -$132K 0.45% 19
2021
Q1 		$618K Sell
4,720
-1,373
-23% -$199K 0.34% 28
2020
Q4 		$637K Buy
6,093
+3,068
+101% +$310K 0.38% 22
2020
Q3 		$214K Sell
3,025
-860
-22% -$60K 0.16% 28
2020
Q2 		$249K Buy
+3,885
New +$213K 0.21% 32

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J. Arnold Wealth Management's MRNA Position: Q4 2021 in Review

J. Arnold Wealth Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 4,238 shares — an estimated $1.63M sold.

J. Arnold Wealth Management first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $1.63M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • J. Arnold Wealth Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • J. Arnold Wealth Management sold 4,238 Moderna shares in Q4 2021, an estimated $1.63M.
  • J. Arnold Wealth Management first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • J. Arnold Wealth Management's Moderna position peaked at $1.63M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on J. Arnold Wealth Management's 13F filing for Q4 2021, filed 16 Feb 2022.